| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IDXX | Common Stock | Options Exercise | $0 | +210 | +3% | $0.000000 | 7,151 | 14 Feb 2023 | Direct | |
| transaction | IDXX | Common Stock | Options Exercise | $0 | +181 | +2.5% | $0.000000 | 7,332 | 14 Feb 2023 | Direct | |
| transaction | IDXX | Common Stock | Options Exercise | $0 | +162 | +2.2% | $0.000000 | 7,440 | 14 Feb 2023 | Direct | |
| transaction | IDXX | Common Stock | Options Exercise | $0 | +86 | +1.1% | $0.000000 | 7,580 | 14 Feb 2023 | Direct | |
| transaction | IDXX | Common Stock | Options Exercise | $0 | +93 | +1.2% | $0.000000 | 7,673 | 14 Feb 2023 | Direct | |
| transaction | IDXX | Common Stock | Tax liability | $147,569 | -293 | -3.8% | $503.65 | 7,380 | 14 Feb 2023 | Direct | |
| transaction | IDXX | Common Stock | Options Exercise | $159,080 | +2,000 | +27% | $79.54* | 9,380 | 14 Feb 2023 | Direct | |
| transaction | IDXX | Common Stock | Sale | $505,059 | -1,000 | -11% | $505.06 | 8,380 | 14 Feb 2023 | Direct | F1 |
| transaction | IDXX | Common Stock | Sale | $157,959 | -313 | -3.7% | $504.66 | 8,067 | 14 Feb 2023 | Direct | F2 |
| transaction | IDXX | Common Stock | Sale | $290,861 | -577 | -7.2% | $504.09 | 7,490 | 14 Feb 2023 | Direct | F3 |
| transaction | IDXX | Common Stock | Sale | $55,310 | -110 | -1.5% | $502.81 | 7,380 | 14 Feb 2023 | Direct | F4 |
| holding | IDXX | Common Stock | 100 | 14 Feb 2023 | by spouse | F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IDXX | Restricted Stock Unit | Options Exercise | -210 | -14% | 1,315 | 14 Feb 2023 | Common Stock | 210 | Direct | F6, F12 | |||
| transaction | IDXX | Restricted Stock Unit | Options Exercise | -181 | -14% | 1,134 | 14 Feb 2023 | Common Stock | 181 | Direct | F7, F12 | |||
| transaction | IDXX | Restricted Stock Unit | Options Exercise | -162 | -14% | 972 | 14 Feb 2023 | Common Stock | 162 | Direct | F8, F12 | |||
| transaction | IDXX | Restricted Stock Unit | Options Exercise | -86 | -8.8% | 886 | 14 Feb 2023 | Common Stock | 86 | Direct | F9, F12 | |||
| transaction | IDXX | Restricted Stock Unit | Options Exercise | -93 | -10% | 793 | 14 Feb 2023 | Common Stock | 93 | Direct | F10, F12 | |||
| transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Options Exercise | -2,000 | -30% | 4,736 | 14 Feb 2023 | Common Stock | 2,000 | $79.54 | Direct | F11, F12 |
| Id | Content |
|---|---|
| F1 | Represents the weighted average price of the shares sold ranging from a low of $505.00 to a high of $505.225 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| F2 | Represents the weighted average price of the shares sold ranging from a low of $504.49 to a high of $504.75 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| F3 | Represents the weighted average price of the shares sold ranging from a low of $503.43 to a high of $504.375 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| F4 | Represents the weighted average price of the shares sold ranging from a low of $502.42 to a high of $503.38 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| F5 | The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein. |
| F6 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2019. |
| F7 | Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. |
| F8 | Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. |
| F9 | Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. |
| F10 | Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023. |
| F11 | Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,993 shares in five annual installments beginning February 15, 2016, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. |
| F12 | Not applicable. |